Louis Brown, MD
Procedural Dermatology · Philadelphia, PANPI 1417081803
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.4% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Sanofi at 27.5% of the total. Reporting peaked in 2019 at $551 and has fallen 94.2% since, to $32 in 2025.
Across 49 payments — averaging $26.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$361
- AbbVie$191
- Johnson & Johnson$188
- UCB, Inc.$134
- Sun Pharmaceutical Industries Inc.$129
- Bristol Myers Squibb$116
- plus $193 from 4 others
What the payments were for
- Food & beverage$1,21392%
- Education$1008%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 20 | $361 |
| AbbVie | 7 | $191 |
| Johnson & Johnson | 5 | $188 |
| UCB, Inc. | 1 | $134 |
| Sun Pharmaceutical Industries Inc. | 3 | $129 |
| Bristol Myers Squibb | 1 | $116 |
| Genentech USA, Inc. | 5 | $72 |
| Amgen | 4 | $58 |
| DUSA Pharmaceuticals, Inc. | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,313 in reported general payments places this provider in the 65th percentile of 26 procedural dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 39 | $2,137 |
| Clobetasol Propionate | 20 | $1,126 |
| Oxycodone Hcl | 43 | $1,097 |
| Clindamycin Phosphate | 26 | $975 |
| Promethazine Hcl | 34 | $665 |
| Alprazolam | 15 | $584 |
| Triamcinolone Acetonide | 30 | $556 |
| Ketoconazole | 36 | $541 |
| Ammonium Lactate | 21 | $485 |
| Mometasone Furoate | 20 | $400 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $302 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $264 |
| Doxycycline Hyclate | 23 | $232 |
| Minoxidil | 23 | $199 |
| Lidocaine | 12 | $153 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Philadelphia
- Barbara MathesPhiladelphia$7K
- Anne AngelesPhiladelphia$2K
- Clifford PerlisPhiladelphia$349
- Steven GreenbaumPhiladelphia$198
- Jonathan WolfePlymouth Meeting$252K
- Stuart GlasserGreensburg$13K
- Danielle DehoratiusBryn Mawr$12K
- Anthony SantoroDoylestown$8K
- Vincent HerbstWilliamsport$4K
- Elizabeth AndersonCamp Hill$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.